Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 9;20(1):299.
doi: 10.1186/s12874-020-01187-5.

A multi-country comparison of stochastic models of breast cancer mortality with P-splines smoothing approach

Affiliations

A multi-country comparison of stochastic models of breast cancer mortality with P-splines smoothing approach

Sumaira Mubarik et al. BMC Med Res Methodol. .

Abstract

Background: Precise predictions of incidence and mortality rates due to breast cancer (BC) are required for planning of public health programs as well as for clinical services. A number of approaches has been established for prediction of mortality using stochastic models. The performance of these models intensely depends on different patterns shown by mortality data in different countries.

Methods: The BC mortality data is retrieved from the Global burden of disease (GBD) study 2017 database. This study include BC mortality rates from 1990 to 2017, with ages 20 to 80+ years old women, for different Asian countries. Our study extend the current literature on Asian BC mortality data, on both the number of considered stochastic mortality models and their rigorous evaluation using multivariate Diebold-Marino test and by range of graphical analysis for multiple countries.

Results: Study findings reveal that stochastic smoothed mortality models based on functional data analysis generally outperform on quadratic structure of BC mortality rates than the other lee-carter models, both in term of goodness of fit and on forecast accuracy. Besides, smoothed lee carter (SLC) model outperform the functional demographic model (FDM) in case of symmetric structure of BC mortality rates, and provides almost comparable results to FDM in within and outside data forecast accuracy for heterogeneous set of BC mortality rates.

Conclusion: Considering the SLC model in comparison to the other can be obliging to forecast BC mortality and life expectancy at birth, since it provides even better results in some cases. In the current situation, we can assume that there is no single model, which can truly outperform all the others on every population. Therefore, we also suggest generating BC mortality forecasts using multiple models rather than relying upon any single model.

Keywords: Breast cancer mortality; Goodness of fits; Lee carter model; Multivariate Diebold-Marino-test; P-splines.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Females breast cancer death rates (per, 100,000) among four countries, 1990–2017, Top horizontal panel = actual death rates, Bottom panel = log death rates
Fig. 2
Fig. 2
Density plots of females’ age-standardized mortality rates (per 100,000) due to breast cancer, by countries, from 1990 to 2017
Fig. 3
Fig. 3
Residuals BC mortality rates from three models, SLC, FDM and BMS, for each country individually
Fig. 4
Fig. 4
In-sample goodness of fit of three models and selection of best fit by multivariate DM test on four countries’ data set, models are fitted for 21 year of BC mortality rates from 1990 to 2010, values on x-axis showing the number of years from 1990 to 2010 with 5 year interval
Fig. 5
Fig. 5
Forecast errors of (a) SLC (b) FDM (c) BMS model across ages by forecast year 2011–2017 for four countries’ data
Fig. 6
Fig. 6
Out-sample goodness of fit of three models and selection of best fit by multivariate DM test on four countries’ data set, 7 year forecast from 2011 to 2017 are compared among the models, values on x-axis representing the code of years from 2011 to 2017
Fig. 7
Fig. 7
Confidence Interval (95%) for the mean forecast error of SLC, FDM and BMS model separately for each country’s data set

References

    1. Hakulinen T. The future cancer burden as a study subject. Acta Oncol. 1996;35(6):665–670. doi: 10.3109/02841869609083996. - DOI - PubMed
    1. Fan L, Goss PE, Strasser-Weippl K. Current status and future projections of breast cancer in Asia. Breast Care. 2015;10(6):372–378. doi: 10.1159/000441818. - DOI - PMC - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Mubarik S, Wang F, Fawad M, Wang Y, Ahmad I, Yu C. Trends and projections in breast cancer mortality among four Asian countries (1990–2017): evidence from five stochastic mortality models. Sci Rep. 2020;10(1):1–12. doi: 10.1038/s41598-020-62393-1. - DOI - PMC - PubMed
    1. Kim Y, Yoo K-Y, Goodman MT. Differences in incidence, mortality and survival of breast cancer by regions and countries in Asia and contributing factors. Asian Pac J Cancer Prev. 2015;16(7):2857–2870. doi: 10.7314/APJCP.2015.16.7.2857. - DOI - PubMed

Publication types